Pages that link to "Q35370283"
Jump to navigation
Jump to search
The following pages link to Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation (Q35370283):
Displaying 9 items.
- Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis (Q26866578) (← links)
- Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition (Q27322429) (← links)
- Cell-based therapies in kidney disease (Q33873259) (← links)
- Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells (Q35665321) (← links)
- Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq. (Q36105915) (← links)
- Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives (Q38156153) (← links)
- Melatonin regulates mesenchymal stem cell differentiation: a review. (Q38197694) (← links)
- Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production (Q49177880) (← links)
- Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor. (Q52861093) (← links)